DRKS00023806
Completed
Not Applicable
ong-term consequences of COVID-19 for pulmonary and neurocognitive disorders - COVIMMUNE-Clin
Klinik für Neurodegenerative Erkrankungen und GerontopsychiatrieUniversitätsklinikum Bonn0 sites162 target enrollmentMarch 16, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Klinik für Neurodegenerative Erkrankungen und GerontopsychiatrieUniversitätsklinikum Bonn
- Enrollment
- 162
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient subjects must belong to one of the following: Asymptomatic or severly affected course of COVID\-19 (SARS\-CoV\-2 positive) infection. Both groups must meet the following criteria:
- •\- written informed consent of the subject
- •\- aged 25 to 75 years
- •\- fulfill the criteria for the respective groups of interest; either to the group of remitted COVID\-19 infection cases with an asymptomatic couse (i.e., no symptoms other than anosmia and/or ageusia) or to the group of remitted COVID\-19 infection cases with a severe course (i.e., requiring hospital stay)
- •\- able and willing to participate throughout the study
- •\- fluent German language abilities
- •Healthy controls will only be included if they meet all of the following criteria
- •\- written informed consent
- •aged 25 to 75 years
- •fluent German language abilities
Exclusion Criteria
- •\- inability to give informed consent
- •\- any condition that clearly interferes with participation in the study
- •\- any condition that interferes with the clinical or neuropsychological study procedures
- •\- sensory impairment that prevents or significantly interferes with neuropsychological testing
- •\- contraindication for MRI
- •\- severe or unstable medical condition
- •\- current major depressive episode
- •\- psychotic disorder, bipolar disorder, substance abuse at present or in the past
- •\- known neurodegenerative disorder (Alzheimer's disease, Parkinson's disease, Frontotemporal dementia, Huntington's disease, Amyotrophic Lateral Sclerosis)
- •\- vascular dementia, history of stroke, or history of malignant disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
ong term Effects of Covid on Pulmonary Function and Quality of Life.CTRI/2022/01/039307one
Completed
Not Applicable
Evaluation Of The Chronic Effects Of Covıd-19 Infection On The Respiratory SystemPost-COVID-19 SyndromeCOVID-19NCT06439134Yeditepe University100
Recruiting
Not Applicable
Impact of COVID-19 Pneumonia on Pulmonary Function, Exercise capacity, Mood disorders, and Quality of Life in Long-term Follow UpPost discharge all subjects with SAR-COV-2 (COVID-19 virus) pneumoniaCOVID,pneumonia,exercise capacity,lung function,mood disordersTCTR20210827005Faculty of Medicine, Chiang Mai University72
Completed
Phase 2
Dual MRI for Cardiopulmonary COVID-19 Long HaulersCovid19NCT04828135Bastiaan Driehuys18
Completed
Not Applicable
Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19Covid19SARS-CoV InfectionPulmonary RehabilitationQuality of LifeNCT04649918Schön Klinik Berchtesgadener Land50